Healthcare provider profile · identity verified

April Ann Rosalez, D.O.

Family Practice · SHELBY, MI · NPI 1255694352

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	306	83
Atorvastatin Calcium	Atorvastatin Calcium	256	71
Lisinopril	Lisinopril	223	70
Amlodipine Besylate	Amlodipine Besylate	199	55
Pantoprazole Sodium	Pantoprazole Sodium	193	49
Losartan Potassium	Losartan Potassium	180	47
Trazodone Hcl	Trazodone Hcl	134	32
Albuterol Sulfate Hfa	Albuterol Sulfate	132	41
Montelukast Sodium	Montelukast Sodium	130	43
Omeprazole	Omeprazole	127	40
Gabapentin	Gabapentin	119	33
Furosemide	Furosemide	112	27
Metformin Hcl	Metformin Hcl	112	33
Tramadol Hcl	Tramadol Hcl	106	20
Potassium Chloride	Potassium Chloride	94	23
Eliquis	Apixaban	91	19
Simvastatin	Simvastatin	90	25
Hydrochlorothiazide	Hydrochlorothiazide	81	27
Escitalopram Oxalate	Escitalopram Oxalate	77	21
Allopurinol	Allopurinol	73	17
Pregabalin	Pregabalin	69	19
Metoprolol Tartrate	Metoprolol Tartrate	65	18
Venlafaxine Hcl Er	Venlafaxine Hcl	64	11
Tamsulosin Hcl	Tamsulosin Hcl	63	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	18
Citalopram Hbr	Citalopram Hydrobromide	53	16
Carvedilol	Carvedilol	52	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	14
Buspirone Hcl	Buspirone Hcl	51	17
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Alprazolam	Alprazolam	45	suppressed
Pravastatin Sodium	Pravastatin Sodium	45	14
Lovastatin	Lovastatin	44	11
Metoprolol Succinate	Metoprolol Succinate	43	15
Ozempic	Semaglutide	41	11
Duloxetine Hcl	Duloxetine Hcl	38	13
Estradiol	Estradiol	38	12
Fluoxetine Hcl	Fluoxetine Hcl	37	11
Lorazepam	Lorazepam	37	suppressed
Meloxicam	Meloxicam	37	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	14
Farxiga	Dapagliflozin Propanediol	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Trulicity	Dulaglutide	36	suppressed
Nystatin	Nystatin	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Sertraline Hcl	Sertraline Hcl	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Finasteride	Finasteride	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Prednisone	Prednisone	25	16
Rosuvastatin Calcium	Rosuvastatin Calcium	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Diazepam	Diazepam	21	suppressed
Eszopiclone	Eszopiclone	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Temazepam	Temazepam	21	suppressed
Torsemide	Torsemide	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Atenolol	Atenolol	17	suppressed
Azithromycin	Azithromycin	17	suppressed
Cephalexin	Cephalexin	17	15
Primidone	Primidone	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Glipizide	Glipizide	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Baclofen	Baclofen	15	suppressed
Famotidine	Famotidine	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Bydureon Bcise	Exenatide Microspheres	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Leflunomide	Leflunomide	12	suppressed
Lybalvi	Olanzapine/Samidorphan Malate	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Belsomra	Suvorexant	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lamotrigine Er	Lamotrigine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error